Meetings: National Institute on Drug Abuse,

Federal Register, June 07, 2000 (Nbr. Vol. 65, No. 110)

Notices - National Institutes of Health
Permanent Link: http://regulations.vlex.com/vid/23048713
Id. vLex: VLEX-23048713

Click here to download this article in graphic format (Acrobat Reader)

Document language

Search in this disposition

Go to article

Sponsored Ads:


Text:



Federal Register: June 7, 2000 (Volume 65, Number 110)NoticesPage 36153From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr07jn00-86

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Phase II SBIR: ``Develop CD-ROM Based Instrument Wizard''.

Date: June 28, 2000.

Time: 10 a.m. to 11:30 a.m.

Agenda: To review and evaluate contract proposals.

Place: Neuroscience Center, National Institutes of Health, 6001 Executive Blvd., Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Eric Zatman, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1438.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS)

Dated: May 31, 2000. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy.

FR Doc. 00-14336Filed6-6-00; 8:45 amBILLING CODE 4140-01-M

Sponsored Ads:




Activate your free trial now

Make your order

Need help? Contact us

Try vLex for FREE for 3 days

Access legal information from United States including:

  • Constitutions
  • Forms and Contracts
  • Legal Books and Journals
  • Case Law
  • News and Business
  • Regulations
  • U.S. Code

Try vLex without any commitment for 3 days and see why you need it.

3

days of Free Access